Immunotherapy-based targeting of MSLN <sup>+</sup> activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis
Takahiro Nishio(University of California San Diego Medical Center), Tatiana Kisseleva(University of California San Diego)
Cited by 29
Related Papers
Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
|Gastroenterology|2012|690
NF-κB regulation of endothelial cell function during LPS-induced toxemia and cancer
|Journal of Clinical Investigation|2006|136
Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis
|Journal of Clinical Investigation|2017|107